poLight ASA (PLT.OL)
NOK 5.01
(-3.65%)
NOK 5.01
(-3.65%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -94.61 Million | -63.6 Million | -49.54 Million | -42.63 Million | -49.53 Million | -79.91 Million |
| Net Income | -85.48 Million | -67.64 Million | -53.38 Million | -50.95 Million | -77.74 Million | -76.92 Million |
| Depreciation & Amortization | 9.67 Million | 10.39 Million | 11.92 Million | 12.13 Million | 26.19 Million | 1.02 Million |
| Deferred income taxes | -58.95 Million | - | 273 Thousand | 946 Thousand | 1.02 Million | - |
| Stock-based compensation | 8.1 Million | 4.82 Million | 4.38 Million | 3.67 Million | 4.87 Million | 4.71 Million |
| Change in working capital | -27.11 Million | -11.07 Million | -12.73 Million | -7.4 Million | -2.4 Million | -8.45 Million |
| Other non-cash items | 57.26 Million | -100 Thousand | -7000.00 | -1.02 Million | -1.48 Million | -283 Thousand |
| Investing Cash Flow | 6000.00 | -9.2 Million | -2.14 Million | -226 Thousand | -2.72 Million | -9.19 Million |
| Investments in PPE | -387 Thousand | -9.2 Million | -2.14 Million | -226 Thousand | -3.25 Million | -11.18 Million |
| Acquisitions | 392 Thousand | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 1000.00 | - | - | - | 526 Thousand | 1.98 Million |
| Financing Cash Flow | 124.99 Million | -710 Thousand | 132.31 Million | 46.61 Million | -1.72 Million | 122.78 Million |
| Debt repayment | -1.08 Million | -964 Thousand | -1.35 Million | -1.11 Million | -600 Thousand | -1.2 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 126.08 Million | 254 Thousand | 141.2 Million | 50.73 Million | - | 134.68 Million |
| Other Financing Activities | 126.08 Million | -964 Thousand | -8.88 Million | -4.12 Million | -1.12 Million | -10.7 Million |
| Accounts receivables | -2.37 Million | 11.92 Million | -11.33 Million | -2.9 Million | -560 Thousand | 532 Thousand |
| Accounts payables | -2.72 Million | 2.57 Million | 9.22 Million | 1.65 Million | -4.71 Million | 57 Thousand |
| Inventory | -24.51 Million | -28.74 Million | -7.66 Million | -1.43 Million | -356 Thousand | -5.59 Million |
| Other working capital | 2.49 Million | 3.16 Million | -2.95 Million | -4.71 Million | 3.23 Million | -2.86 Million |
| Cash at beginning of period | 84.24 Million | 157.81 Million | 77.2 Million | 73.46 Million | 127.42 Million | 93.64 Million |
| Cash at end of period | 114.78 Million | 84.24 Million | 157.81 Million | 77.2 Million | 73.46 Million | 127.42 Million |
| Capital Expenditure | -387 Thousand | -9.2 Million | -2.14 Million | -226 Thousand | -3.25 Million | -11.18 Million |
| Effect of forex changes on cash | 169 Thousand | -49 Thousand | -26 Thousand | -9000.00 | 20 Thousand | 110 Thousand |
| Net cash flow / Change in cash | 30.53 Million | -73.56 Million | 80.6 Million | 3.74 Million | -53.96 Million | 33.77 Million |
| Free Cash Flow | -95 Million | -72.8 Million | -51.68 Million | -42.85 Million | -52.78 Million | -91.1 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -25.77 Million | -22.76 Million | -20.46 Million | -27.56 Million | -85.48 Million | -21.46 Million |
| Depreciation & Amortization | 2.63 Million | 2.53 Million | 2.66 Million | 2.5 Million | 9.67 Million | 2.61 Million |
| Deferred income taxes | - | - | - | -3.34 Million | -58.95 Million | -6000.00 |
| Stock-based compensation | - | 1.34 Million | 2.19 Million | 2.92 Million | 8.1 Million | 3.19 Million |
| Change in working capital | 1.4 Million | -386 Thousand | -3.56 Million | 4.34 Million | -27.11 Million | -4.46 Million |
| Other non-cash items | 2.75 Million | 6.78 Million | 11.07 Million | 3.39 Million | 57.26 Million | -198 Thousand |
| Investing Cash Flow | -37 Thousand | -289 Thousand | -595 Thousand | 115 Thousand | 6000.00 | -28 Thousand |
| Investments in PPE | -37 Thousand | -289 Thousand | -595 Thousand | -278 Thousand | -387 Thousand | -28 Thousand |
| Acquisitions | - | - | - | 392 Thousand | 392 Thousand | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | 392 Thousand | 1000.00 | - |
| Financing Cash Flow | -309 Thousand | 123.65 Million | 186 Thousand | -318 Thousand | 124.99 Million | 2000.00 |
| Debt repayment | -14 Thousand | -19 Thousand | -469 Thousand | -318 Thousand | -1.08 Million | -262 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | 123.96 Million | - | - | 126.08 Million | 287 Thousand |
| Other Financing Activities | -295 Thousand | -293 Thousand | - | - | 126.08 Million | -285 Thousand |
| Accounts receivables | 2.14 Million | -4.92 Million | 2.27 Million | -851 Thousand | -2.37 Million | -1.54 Million |
| Accounts payables | -3.32 Million | 1.51 Million | -8.13 Million | 5.9 Million | -2.72 Million | -3.82 Million |
| Inventory | 1.29 Million | 3.01 Million | 2.29 Million | -457 Thousand | -24.51 Million | -3.35 Million |
| Other working capital | 1.28 Million | 1.51 Million | - | -252 Thousand | 2.49 Million | 4.25 Million |
| Cash at beginning of period | 199.31 Million | 95.33 Million | 114.78 Million | 132.77 Million | 84.24 Million | 153.17 Million |
| Cash at end of period | 180.14 Million | 199.31 Million | 95.33 Million | 114.78 Million | 114.78 Million | 132.77 Million |
| Capital Expenditure | -37 Thousand | -289 Thousand | -595 Thousand | -278 Thousand | -387 Thousand | -28 Thousand |
| Effect of forex changes on cash | - | -96 Thousand | 133 Thousand | -25 Thousand | 169 Thousand | -56 Thousand |
| Net cash flow / Change in cash | -19.17 Million | 103.98 Million | -19.45 Million | -17.98 Million | 30.53 Million | -20.4 Million |
| Free Cash Flow | -19 Million | -19.57 Million | -19.77 Million | -18.02 Million | -95 Million | -20.34 Million |
PVCT
BIOVIC-B
EDRWY
GXH
BEWFF
8433